SynGAP10 weekly 10 minute updates on SYNGAP1

Author: Syngap Research Fund, 501(c)(3)

Over 1,600 families are caring for a loved one with the rare disease SynGAP resulting from a variant of the SYNGAP1 gene. This weekly podcast is for them. -A quick summary of the latest news in the space. The host is Mike Graglia, co-founder & managing director of CURE SYNGAP1. CURE SYNGAP1 is a parent-led public charity in the US that strives to accelerate research into treatments for SYNGAP1 so that we can help our loved ones in a timeframe that matters. Learn more at https://cureSYNGAP1.org
Be a guest on this podcast

Language: en

Genres: Business, Health & Fitness, Medicine, Non-Profit

Contact email: Get it

Feed URL: Get it

iTunes ID: Get it

Get all podcast data

Listen Now...

Stoke Tx shows us that ASO Clinical Development is accelerating. #S10e196
Episode 197
Friday, 16 January, 2026

Friday, January 16, 2026 - Week 3 Stoke Phase 3 Rapid Recruitment - A timeline that is ours to beat! https://investor.stoketherapeutics.com/news-releases/news-release-details/stoke-therapeutics-announces-updates-timelines-completion If Marcin can make it from Poland, you can make it from where you are! cureSYNGAP1.org/Marcin CAMP4 Website is great and features Dani Williams! https://www.camp4tx.com/ Newsletter is out! https://cureSYNGAP1.org/NL49 Sara Driscoll Genetic Testing Story - Share it or copy it! https://cureSYNGAP1.org/GenTest Pubmed 2026 is at 3! https://pubmed.ncbi.nlm.nih.gov/?term=syngap1&filter=years.2026-2026&sort=date SOCIAL MATTERS 4,604 LinkedIn. https://www.linkedin.com/company/curesyngap1/ 1,510 YouTube. https://www.youtube.com/@CureSYNGAP1 11.2k Twitter https://twitter.com/cureSYNGAP1 45k Insta https://www.instagram.com/curesyngap1/ $CAMP stock is at $5.78 on 15 Jan. ‘26 https://www.google.com/finance/beta/quote/CAMP:NASDAQ Like and subscribe to this podcast wherever you listen. https://curesyngap1.org/podcasts/syngap10/ Episode 196 of #Syngap10 #CureSYNGAP1 #Podcast